| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 87.458 | 4.344 | 0 | - | - | - | 0 | 0 | 0 | 0 |
| Total Income - EUR | 87.510 | 4.344 | 0 | - | - | - | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 61.850 | 10.288 | 2.658 | - | - | - | 40 | 160 | 0 | 0 |
| Gross Profit/Loss - EUR | 25.659 | -5.944 | -2.658 | - | - | - | -40 | -160 | 0 | 0 |
| Net Profit/Loss - EUR | 23.030 | -6.031 | -2.658 | - | - | - | -40 | -160 | 0 | 0 |
| Employees | 2 | 1 | 0 | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Animus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49.764 | 48.659 | 47.157 | - | - | - | 43.622 | 43.757 | 43.624 | 43.380 |
| Current Assets | 8.311 | 16.482 | 13.879 | - | - | - | 13.530 | 13.412 | 13.371 | 13.296 |
| Inventories | 360 | 2.342 | 670 | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | 7.486 | 0 | 0 | - | - | - | 249 | 250 | 249 | 248 |
| Cash | 465 | 14.140 | 13.209 | - | - | - | 13.281 | 13.162 | 13.122 | 13.049 |
| Shareholders Funds | 50.223 | 42.109 | 38.739 | - | - | - | 34.964 | 34.913 | 34.807 | 34.613 |
| Social Capital | 45 | 45 | 44 | - | - | - | 40 | 41 | 40 | 40 |
| Debts | 7.856 | 23.033 | 22.297 | - | - | - | 22.187 | 22.256 | 22.188 | 22.064 |
| Income in Advance | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Animus Med Srl